IHL 675A
Multi use anti inflammatory as stated by the FDA and a prophylactic drug candidate used for the treatment of ARDS - COPD - RA - COVID /SARS
Global market application in unmet need .....no competing drug candidates so a vacant commercial opportunity worth billions annually
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-19711
-
-
- There are more pages in this discussion • 204 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)